<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<office:document-content xmlns:anim="urn:oasis:names:tc:opendocument:xmlns:animation:1.0" xmlns:chart="urn:oasis:names:tc:opendocument:xmlns:chart:1.0" xmlns:config="urn:oasis:names:tc:opendocument:xmlns:config:1.0" xmlns:db="urn:oasis:names:tc:opendocument:xmlns:database:1.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dr3d="urn:oasis:names:tc:opendocument:xmlns:dr3d:1.0" xmlns:draw="urn:oasis:names:tc:opendocument:xmlns:drawing:1.0" xmlns:fo="urn:oasis:names:tc:opendocument:xmlns:xsl-fo-compatible:1.0" xmlns:form="urn:oasis:names:tc:opendocument:xmlns:form:1.0" xmlns:grddl="http://www.w3.org/2003/g/data-view#" xmlns:math="http://www.w3.org/1998/Math/MathML" xmlns:meta="urn:oasis:names:tc:opendocument:xmlns:meta:1.0" xmlns:number="urn:oasis:names:tc:opendocument:xmlns:datastyle:1.0" xmlns:office="urn:oasis:names:tc:opendocument:xmlns:office:1.0" xmlns:presentation="urn:oasis:names:tc:opendocument:xmlns:presentation:1.0" xmlns:script="urn:oasis:names:tc:opendocument:xmlns:script:1.0" xmlns:smil="urn:oasis:names:tc:opendocument:xmlns:smil-compatible:1.0" xmlns:style="urn:oasis:names:tc:opendocument:xmlns:style:1.0" xmlns:svg="urn:oasis:names:tc:opendocument:xmlns:svg-compatible:1.0" xmlns:table="urn:oasis:names:tc:opendocument:xmlns:table:1.0" xmlns:text="urn:oasis:names:tc:opendocument:xmlns:text:1.0" xmlns:xforms="http://www.w3.org/2002/xforms" xmlns:xhtml="http://www.w3.org/1999/xhtml" xmlns:xlink="http://www.w3.org/1999/xlink" office:version="1.2"><office:font-face-decls><style:font-face style:name="Liberation Serif" svg:font-family="Liberation Serif" style:font-family-generic="roman" style:font-pitch="variable"/><style:font-face style:name="AR PL SungtiL GB" svg:font-family="AR PL SungtiL GB" style:font-family-generic="system" style:font-pitch="variable"/><style:font-face style:name="Lohit Devanagari" svg:font-family="Lohit Devanagari" style:font-family-generic="system" style:font-pitch="variable"/><style:font-face style:name="Times New Roman" svg:font-family="Times New Roman" style:font-family-generic="roman" style:font-pitch="variable" svg:panose-1="2 2 6 3 5 4 5 2 3 4"/><style:font-face style:name="Liberation Sans" svg:font-family="Liberation Sans" style:font-family-generic="swiss" style:font-pitch="variable"/><style:font-face style:name="Liberation Mono" svg:font-family="Liberation Mono" style:font-family-generic="modern" style:font-pitch="fixed"/><style:font-face style:name="Calibri Light" svg:font-family="Calibri Light" style:font-family-generic="swiss" style:font-pitch="variable" svg:panose-1="2 15 3 2 2 2 4 3 2 4"/><style:font-face style:name="Calibri" svg:font-family="Calibri" style:font-family-generic="swiss" style:font-pitch="variable" svg:panose-1="2 15 5 2 2 2 4 3 2 4"/></office:font-face-decls><office:automatic-styles><style:style style:name="P1" style:parent-style-name="PreformattedText" style:master-page-name="MP0" style:family="paragraph"><style:paragraph-properties fo:break-before="page"/></style:style></office:automatic-styles><office:body><office:text text:use-soft-page-breaks="true"><text:p text:style-name="P1">[Un homme] [de 80 ans] [a ingéré] [une solution insecticide] [contenant]<text:s/><text:span text:style-name="ne-connais-pas">[de la bifenthrine]</text:span><text:s/>. <text:s/>Il [a été admis] [en urgence] [à l&apos;hôpital conscient] , et [les tests biologiques réalisés] [ont montré]<text:s/><text:span text:style-name="ne-connais-pas">[une<text:s/></text:span><text:span text:style-name="ne-connais-pas">hypoalbuminémie]</text:span><text:s/>[avec un taux]<text:s/><text:span text:style-name="ne-connais-pas">[de prothrombine]<text:s/></text:span>[à 62 %] et<text:s/><text:span text:style-name="ne-connais-pas">[une faible hypoxemie]</text:span><text:s/>[L&apos;électrocardiogramme] [et les examens cardiaques et pulmonaires] [étaient] [normaux] . <text:s/>[La tomographie cérébrale] [s&apos;est révélée] [normale] elle [aussi] ,<text:s/><text:span text:style-name="ne-connais-pas">[exception<text:s/></text:span><text:span text:style-name="ne-connais-pas">faite de quelques calcifications bilatérales]</text:span><text:s/>. <text:s/>[L&apos;évolution clinique] [a été] [favorable] et [le patient] [a pu] [quitter] [l&apos;hôpital] [après quelques jours] . <text:s/>[Les cas] [d&apos;intoxication aiguës]<text:s/><text:span text:style-name="ne-connais-pas">[aux pyréthrinoïdes]</text:span><text:s/>[sont] [rares] ( [1 ,] [7] ) . <text:s/>[Les ingestions suicidaires] [se manifestent] [essentiellement] [par la stimulation] du SNC et [par des troubles musculaires] ( [tremblements] ,<text:s/><text:span text:style-name="ne-connais-pas">[myoclonies ,]</text:span><text:s/>[convulsions] ) [pouvant] [aboutir]<text:s/><text:span text:style-name="ne-connais-pas">[à la catatonie]</text:span><text:s/>. <text:s/>[Des manifestations] [ORL et respiratoires]<text:s/>( [toux] ,<text:s/><text:span text:style-name="ne-connais-pas">[bronchospasme]</text:span><text:s/>) [peuvent] [être observées] [chez les sujets sensibles] . <text:s/>[Généralement] , [le traitement] [est] [symptomatique] . <text:s/>[L&apos;adrénaline] [est requise] [contre les réactions] [d&apos;hypersensibilité]<text:s/><text:span text:style-name="ne-connais-pas">[aux pyréthrinoïdes]<text:s/></text:span>. <text:s/>Il [n&apos;existe] [aucun antidote] [contre l&apos;intoxication]<text:s/><text:span text:style-name="ne-connais-pas">[aux pyréthrinoïdes]</text:span><text:s/>. <text:s/>[Une concentration fatale] [à 710 mg] / l [a été rapportée] [suite à un contact] [sur la peau] , [en milieu professionnel] ( [7] ) . <text:s/>[Notre méthode] [a permis] [de déterminer] [une concentration] [de 20 µg] / l [dans le sérum] ( [Fig. 3 )] , [en accord avec la symptomatologie et] [l&apos;évolution clinique] [du patient] . <text:s text:c="7"/></text:p></office:text></office:body></office:document-content>